[1]
Kimball, A.B. , Alavi, A., Jemec, G.B., Gottlieb, A., Wei, X., Wozniak, M.B., Uhlmann, L., Martinez, A.L., Keefe, D., Martin, R., Chen, L. and Muscianisi, E. 2023. Secukinumab in Moderate to Severe Hidradenitis Suppurativa: Primary Endpoint Analysis From the SUNSHINE and SUNRISE Phase 3 Trials. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s129. DOI:https://doi.org/10.25251/skin.7.supp.129.